Contact

It's the GeneMedi's summary page for Target/Biomarker Introduction of TACSTD2. The page also collects GeneMedi's different modalities and formats products for TACSTD2 in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi's target-insight database-GM ITD database, the TACSTD2 target is also connected to human indications/diseases/conditions/MOA.

Target sublocation: Introcelluar Protein.

This intronless gene encodes a carcinoma-associated antigen. This antigen is a cell surface receptor that transduces calcium signals. Mutations of this gene have been associated with gelatinous drop-like corneal dystrophy.[provided by RefSeq, Dec 2009]

Target IDGM-IP0030
Target NameTACSTD2
Gene ID4070
Gene Official NameTACSTD2
Gene AliasEGP-1, EGP1, GA733-1, GA7331, GP50, M1S1, TROP2
Protein Sub-locationIntrocelluar Protein
CategoryTherapeutics Target, INN Index, Immuno-oncology Target


Pre-made TACSTD2-specific INN-index biosimilar (antibody&conjugates)-sacituzumab govitecan, Sacituzumab, Datopotamab, datopotamab deruxtecan

Anti-TACSTD2 therapeutic INN-index antibodies and conjugates are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody for drug discovery, target MOA research, cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Cat No.Products Name (INN Index)INN Name Previous Name Target FormatOrder
GMP-Bios-INN-983Pre-Made Sacituzumab Govitecan Biosimilar, Whole Mab Adc, Anti-Tacstd2 Antibody: Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2 therapeutic antibody Drug Conjugatesacituzumab govitecanTACSTD2Whole mAb ADCINN mab
GMP-Bios-ab-503Pre-Made Sacituzumab biosimilar, Whole mAb ADC, Anti-TACSTD2 Antibody: Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2 therapeutic antibodySacituzumabTACSTD2Whole mAb ADCINN mab
GMP-Bios-ab-134Pre-Made Datopotamab biosimilar, Whole mAb, Anti-TACSTD2 Antibody: Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2 therapeutic antibodyDatopotamabTACSTD2Whole mAbINN mab
GMP-Bios-INN-796Pre-Made Datopotamab Deruxtecan Biosimilar, Whole Mab Adc, Anti-Tacstd2 Antibody: Anti-EGP-1/EGP1/GA733-1/GA7331/GP50/M1S1/TROP2 therapeutic antibody Drug Conjugatedatopotamab deruxtecanTACSTD2Whole mAb ADCINN mab



Pre-made anti-TACSTD2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research.

Pre-made anti-TACSTD2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-TACSTD2 mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Cat No.Antibody NameFormatClassified by tagOrder
GM-Tg-hg-IP0030-AbAnti-TACSTD2 monoclonal antibodymabTherapeutics Target antibodymonoclonal antibody.




GENEMEDI
6th Floor, Building No.2, Kangxin Road 3377, Shanghai, China
Email: [email protected]   [email protected]
Telephone: +86-21-50478399   Fax: 86-21-50478399
Privacy Policy
Chinese Website

Apply for
Free
Sample

Sample FOC application

×